{"id":684820,"date":[{"year":1984,"month":10,"day":17}],"page":"2","source":"本报","region":"沈阳","masthead":"","special_issue":"","column":"","genre":"","count":"355","ytitle":"","mtitle":"一种新型抗癌药物研制成功 二军大培育出实验鼠新品系","ftitle":"","authors":["方静","蒋和平"],"text":[{"type":"paragraph","text":"本报沈阳专讯　一种抗癌药物新剂型——多相脂质体，日前在沈阳宣告研制成功。"},{"type":"paragraph","text":"以往的抗癌药物在临床中，常常因毒副作用大，导致患者造血机能到伤，不得不停止用药，多相脂质体新剂型克服了这个弊端。经过四百九十四例临床观察，患者普遍自觉症状好转，并不同程度地增强了免疫功能。"},{"type":"paragraph","text":"多相脂质体新剂型是以沈阳药学院顾学裘教授和上海长宁区中心医院副主任药师马竹卿为首的联合攻关组研制的。"},{"type":"paragraph","text":"(方静)"},{"type":"paragraph","text":"本报讯　二军大科研人员培育成功一株实验小鼠新品系，为我国进行疟疾和乳腺癌的研究创造了条件。参加签定的专家认为，这是我国实验动物开发的一个重大创举，为我国实验动物的培育提供了宝贵经验。为了培育这一品系，二军大动物管理所的同志在军内外有关单位的协作下，经历了长达七年的摸索和研究。"},{"type":"paragraph","text":"(蒋和平)"}]}